Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

PKA IIα reg Activators

PKA IIα reg Activators refer to a class of molecules that activate the type IIα regulatory (R) subunit of Protein Kinase A (PKA). PKA, or cyclic AMP (cAMP)-dependent protein kinase, is a crucial enzyme in the intracellular signal transduction pathway. This enzyme plays a pivotal role in transducing cellular responses to various extracellular signals and hormones through the cyclic AMP (cAMP) pathway. PKA itself is a tetrameric holoenzyme composed of two regulatory (R) and two catalytic (C) subunits. In the absence of cAMP, the R subunits bind to and inhibit the C subunits. Upon binding of cAMP to the R subunits, the C subunits are released and can then phosphorylate target proteins, thereby modulating their activity.

The PKA holoenzyme exists in several isoforms, among which type IIα is one. The activation of the type IIα R subunit, specifically by PKA IIα reg Activators, prompts a conformational change that releases the bound catalytic subunits. The free catalytic subunits then initiate a series of phosphorylation events on specific serine or threonine residues of target proteins, leading to altered protein function and cellular responses. These activators do not directly stimulate cAMP production but instead mimic its effects, leading to activation of the PKA pathway. Since cAMP signaling and, by extension, PKA activation are involved in a myriad of physiological processes, including metabolism, gene transcription, and cell differentiation, PKA IIα reg Activators can profoundly influence cellular function by modulating these processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin is known to directly activate adenylate cyclase, leading to increased cAMP levels. Elevated cAMP can subsequently activate PKA. While not directly inducing the expression of PKA IIα reg, forskolin can activate pathways in which PKA plays a crucial role.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX is a non-specific phosphodiesterase inhibitor, which prevents the breakdown of cAMP. Elevated cAMP levels can activate PKA pathways.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$126.00
$328.00
30
(1)

8-Bromo-cAMP is a cell-permeable cAMP analog. By mimicking cAMP, it can activate PKA pathways and potentially influence its expression.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram inhibits phosphodiesterase 4 (PDE4) leading to increased cAMP levels, which can activate PKA pathways.

Cilostamide (OPC 3689)

68550-75-4sc-201180
sc-201180A
5 mg
25 mg
$92.00
$357.00
16
(1)

Cilostamide is a specific PDE3 inhibitor. By increasing cAMP levels, it can subsequently influence PKA pathways.

Dipyridamole

58-32-2sc-200717
sc-200717A
1 g
5 g
$31.00
$102.00
1
(1)

Dipyridamole inhibits various phosphodiesterases, leading to elevated cAMP and cGMP levels. This can in turn influence PKA activity.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$32.00
$85.00
6
(0)

Theophylline inhibits phosphodiesterase, preventing the degradation of cAMP, thus can influence PKA activity.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$105.00
$250.00
8
(2)

Zaprinast inhibits phosphodiesterases, leading to elevated cGMP levels which might cross-talk with cAMP and PKA pathways.

Pentoxifylline

6493-05-6sc-203184
1 g
$20.00
3
(1)

Pentoxifylline is a non-selective phosphodiesterase inhibitor, which can lead to increased cAMP levels, influencing PKA activity.

Vinpocetine

42971-09-5sc-201204
sc-201204A
sc-201204B
20 mg
100 mg
15 g
$55.00
$214.00
$2400.00
4
(1)

Vinpocetine is a phosphodiesterase inhibitor, increasing cAMP levels, which can influence PKA pathways.